On the cusp of artificial intelligence (AI) becoming a ubiquitous feature of our everyday lives, researchers discover that intelligent systems thinking offers a wealth of potential applications in the fight against a cunning human adversary: Cancer.
The global giants believe the strategic moves will make their businesses stronger and more profitable long-term.
For private equity and venture capital investors alike, there are five key trends presenting both headwinds and tailwinds that may impact investment flows into 2022.
The industry association says the shortage has become a serious, industry-wide problem for companies involved in manufacturing medical technologies.
China’s medical device market has grown significantly over the last five years, but with that growth comes some pitfalls.
The market dynamics for telehealth and virtual care continue to evolve, and virtual care ecosystem players must understand how consumers have experienced these changes to better position themselves and design their solutions.
The talent behind a company’s solutions is its biggest competitive advantage. For many medtech companies, attracting candidates requires taking a fresh look at the recruiting and retention process.
Although opportunities in Japan are still considerable, foreign device companies need to do their homework to be successful.
Digital transformation is especially important to medical device manufacturers because they must have good quality data, and especially tracking metrics, to track complaints and device performance to comply with regulatory requirements. And these requirements are just getting stricter.
The application of AI in telehealth to allow doctors to make real-time, data-driven rich choices is a key component in generating a better patient experience and improved health outcomes.
